Johns Hopkins School of Medicine - Drug Development Unit ( Site 0002)

Baltimore, Maryland 21287

0 studies enrolling now · 1 studies all time

What they study most

HIV-1 Infection

Studies at this site

• Safety and Pharmacokinetics of Oral Islatravir (MK-8591) Once Monthly in Participants at Low Risk of Human Immunodeficiency Virus 1 (HIV-1) Infection (MK-8591-016) — Completed